BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 28236059)

  • 21. Oncogenic alterations in papillary thyroid cancers of young patients.
    Sassolas G; Hafdi-Nejjari Z; Ferraro A; Decaussin-Petrucci M; Rousset B; Borson-Chazot F; Borbone E; Berger N; Fusco A
    Thyroid; 2012 Jan; 22(1):17-26. PubMed ID: 22150560
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [
    Zhang X; Su X; Chen WC; Li Y; Yang ZY; Deng WZ; Deng TC; Yang AK
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jun; 52(6):435-439. PubMed ID: 28635216
    [No Abstract]   [Full Text] [Related]  

  • 23. Molecular Profiling of Papillary Thyroid Carcinoma in Korea with a High Prevalence of BRAF
    Lee SE; Hwang TS; Choi YL; Kim WY; Han HS; Lim SD; Kim WS; Yoo YB; Kim SK
    Thyroid; 2017 Jun; 27(6):802-810. PubMed ID: 28293988
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of specific gene rearrangements by fluorescence in situ hybridization in 16 cases of clear cell sarcoma of soft tissue and 6 cases of clear cell sarcoma-like gastrointestinal tumor.
    Segawa K; Sugita S; Aoyama T; Kubo T; Asanuma H; Sugawara T; Ito Y; Tsujiwaki M; Fujita H; Emori M; Hasegawa T
    Diagn Pathol; 2018 Sep; 13(1):73. PubMed ID: 30219084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of RET/PTC rearrangements in thyroid papillary carcinomas: effects of the detection methods and genetic heterogeneity.
    Zhu Z; Ciampi R; Nikiforova MN; Gandhi M; Nikiforov YE
    J Clin Endocrinol Metab; 2006 Sep; 91(9):3603-10. PubMed ID: 16772343
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of NTRK1/3 Rearrangements in Papillary Thyroid Carcinoma Using Immunohistochemistry, Fluorescent In Situ Hybridization, and Next-Generation Sequencing.
    Lee YC; Chen JY; Huang CJ; Chen HS; Yang AH; Hang JF
    Endocr Pathol; 2020 Dec; 31(4):348-358. PubMed ID: 32880785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrated multimodal genetic testing of Ewing sarcoma--a single-institution experience.
    Warren M; Weindel M; Ringrose J; Venable C; Reyes A; Terashima K; Rao P; Chintagumpala M; Hicks MJ; Lopez-Terrada D; Lu XY
    Hum Pathol; 2013 Oct; 44(10):2010-9. PubMed ID: 23706910
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinicopathologic correlations of the BRAFV600E mutation, BRAF V600E immunohistochemistry, and BRAF RNA in situ hybridization in papillary thyroid carcinoma.
    Jung YY; Yoo JH; Park ES; Kim MK; Lee TJ; Cho BY; Chung YJ; Kang KH; Ahn HY; Kim HS
    Pathol Res Pract; 2015 Feb; 211(2):162-70. PubMed ID: 25468810
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pitfalls in RET Fusion Detection Using Break-Apart FISH Probes in Papillary Thyroid Carcinoma.
    Liu Y; Wu S; Zhou L; Guo Y; Zeng X
    J Clin Endocrinol Metab; 2021 Mar; 106(4):1129-1138. PubMed ID: 33382428
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The correlation between BRAF mutations, RET/PTC rearrangements and platelet-derived growth factor B expression in papillary thyroid carcinomas].
    Wang P; Wang YG; Zhao WJ; Fu YD; Wang L; Wang F; Zhao SH
    Zhonghua Nei Ke Za Zhi; 2012 Dec; 51(12):987-91. PubMed ID: 23327964
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BRAF(V599E) mutation is the leading genetic event in adult sporadic papillary thyroid carcinomas.
    Puxeddu E; Moretti S; Elisei R; Romei C; Pascucci R; Martinelli M; Marino C; Avenia N; Rossi ED; Fadda G; Cavaliere A; Ribacchi R; Falorni A; Pontecorvi A; Pacini F; Pinchera A; Santeusanio F
    J Clin Endocrinol Metab; 2004 May; 89(5):2414-20. PubMed ID: 15126572
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increase in Papillary Thyroid Cancer Incidence Is Accompanied by Changes in the Frequency of the BRAF V600E Mutation: A Single-Institution Study.
    Kowalska A; Walczyk A; Kowalik A; Pałyga I; Trybek T; Kopczyński J; Kajor M; Chrapek M; Pięciak L; Chłopek M; Góźdź S; Kamiński G
    Thyroid; 2016 Apr; 26(4):543-51. PubMed ID: 26889698
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical and Morphologic Features of ETV6-NTRK3 Translocated Papillary Thyroid Carcinoma in an Adult Population Without Radiation Exposure.
    Seethala RR; Chiosea SI; Liu CZ; Nikiforova M; Nikiforov YE
    Am J Surg Pathol; 2017 Apr; 41(4):446-457. PubMed ID: 28125451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. KIF5B/RET Rearrangement in a Carcinoma of the Thyroid Gland: A Case Report of a Fatal Disease.
    Viola D; Giani C; Mazzeo S; Ugolini C; Ciampi R; Molinaro E; Agate L; Borrelli N; Chella A; Fontanini G; Basolo F; Elisei R
    J Clin Endocrinol Metab; 2017 Sep; 102(9):3091-3096. PubMed ID: 28911147
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Expressions of wildtype-RET and RET/PTC rearrangements in sporadic adult papillary thyroid carcinoma and their clinicopathologic correlation].
    Zhu XL; Zhou XY; Zhang TM; Zhu XZ
    Zhonghua Bing Li Xue Za Zhi; 2006 Feb; 35(2):87-91. PubMed ID: 16630482
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clear cell myoepithelial carcinoma of salivary glands showing EWSR1 rearrangement: molecular analysis of 94 salivary gland carcinomas with prominent clear cell component.
    Skálová A; Weinreb I; Hyrcza M; Simpson RH; Laco J; Agaimy A; Vazmitel M; Majewska H; Vanecek T; Talarčik P; Manajlovic S; Losito SN; Šteiner P; Klimkova A; Michal M
    Am J Surg Pathol; 2015 Mar; 39(3):338-48. PubMed ID: 25581728
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High prevalence of BRAF gene mutation in papillary thyroid carcinomas and thyroid tumor cell lines.
    Xu X; Quiros RM; Gattuso P; Ain KB; Prinz RA
    Cancer Res; 2003 Aug; 63(15):4561-7. PubMed ID: 12907632
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of ret/PTC-1 rearrangements in neoplastic thyroid tissue using TaqMan RT-PCR.
    Sheils OM; O'Leary JJ; Sweeney EC
    J Pathol; 2000 Sep; 192(1):32-6. PubMed ID: 10951397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Dose-Response Dependences for Frequency of RET/PTC Gene Rearrangements in Papillary Thyroid Carcinoma after Irradiation. Simple Pooling Analysis of Molecular Epidemiological Data].
    Koterov AN; Ushenkova LN; Biryukov AP
    Radiats Biol Radioecol; 2016; 56(1):5-25. PubMed ID: 27245001
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overexpression of wild-type c-RET and zero prevalence of RET/PTC rearrangements are associated with papillary thyroid cancer (PTC) in Kuwait.
    El-Abdallah AA; Junaid TA
    Exp Mol Pathol; 2011 Feb; 90(1):61-5. PubMed ID: 20950609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.